Eikon Therapeutics, Inc. Common Stock (EIKN) Live Share Price, Invest From India

Eikon Therapeutics, Inc. Common Stock Stock Performance

as on May 13, 2026 at 6:59 am IST

Day's Low
Day's High
$9.91
Day's Price Range
$12.05
$11.51
13.90%
Downside
4.69%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$11.51
100.00%
Downside
-100.00%
Upside

Eikon Therapeutics, Inc. Common Stock share price movements today

Previous Close: $9.95
Open: $10.40
Volume: 584.6K
Day's Low - High: $9.91 - $12.05

Eikon Therapeutics, Inc. Common Stock Historical Returns

1 Month Return: + 10.56 %
3 Month Return: -32.91 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Eikon Therapeutics, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Eikon Therapeutics, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$536.8M

EPS (TTM)

-5.8047

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-125.02%

Eikon Therapeutics, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eikon Therapeutics, Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Eikon Therapeutics, Inc. Common Stock	NA	$536.8M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.4B	113.59%	74.13	12.55%
BeiGene, Ltd.	NA	$32.2B	NA	70.46	8.94%
Vertex Pharmaceuticals Inc	BUY	$109.1B	104.61%	25.51	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.9B	40.55%	17.45	29.65%

Indian Investors' Interest in Eikon Therapeutics, Inc. Common Stock Stock

Search interest for Eikon Therapeutics, Inc. Common Stock Stock has decreased by -93% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:-93% versus previous 30 day period

Eikon Therapeutics, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2024	Dec 2025
Total Revenue	-	-
Gross Profit	-	-
Operating Income	-67	-83
EBITDA	-	-
Interest Expense	0	0
Depreciation	6	5
Income Before Tax	-64	-79
Income Tax Expense	-	-
Net Income	-64	-79
Net Profit Margin	0.00%	0.00%

Eikon Therapeutics, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-
Gross Profit	-	-	-
Operating Income	-265	-260	-338
EBITDA	-	-	-
Interest Expense	0	0	0
Depreciation	17	25	24
Income Before Tax	-241	-243	-324
Income Tax Expense	-	-	-
Net Income	-241	-243	-324
Net Profit Margin	0.00%	0.00%	0.00%

Eikon Therapeutics, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2025
Net Income	-79
Operating Cash Flow	-41
Investing Cash Flow	-
Financing Cash Flow	1
Change in Cash	0

Eikon Therapeutics, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2024	Dec 2025
Net Income	-243	-324
Operating Cash Flow	-134	-188
Investing Cash Flow	-	-
Financing Cash Flow	0	352
Change in Cash	16	-17

Insights on Eikon Therapeutics, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 3 months, EIKN stock has moved down by -33.9%

About Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.

Organisation	Eikon Therapeutics, Inc. Common Stock
Headquarters	230 Harriet Tubman Way, Millbrae, CA, United States, 94030
Industry	Biotechnology
CEO	Dr. Roger M. Perlmutter M.D., Ph.D.
E-voting on shares	Click here to vote

Key Management of Eikon Therapeutics, Inc. Common Stock

Name	Title
Dr. Eric Betzig Ph.D.	Co-Founder & Member of Scientific Advisory Board
Dr. Alfred Lloyd Bowie Jr., Ph.D.	Treasurer & CFO
Mr. Benjamin Bruno Thorner	Secretary, General Counsel & Chief Business Officer
Ms. Barbara Howes M.B.A.	Chief People Officer
Dr. Roger M. Perlmutter M.D., Ph.D.	Chairman, President & CEO
Mr. Michael A. Klobuchar	Chief Operating Officer
Dr. Roy D. Baynes FACP, M.D., Ph.D.	Executive VP & Chief Medical Officer
Dr. Robert Tjian Ph.D.	Co-Founder & Member of Scientific Advisory Board
Mr. Russ Berman	Chief Technology Officer

FAQs

What is Eikon Therapeutics, Inc. Common Stock share price today?

Eikon Therapeutics, Inc. Common Stock share price today is $11.51 as on May 13, 2026 at 1:29 am IST at the close of the market. Eikon Therapeutics, Inc. Common Stock share today touched a day high of $12.05 and a low of $9.91.

What is the 52 week high and 52 week low for Eikon Therapeutics, Inc. Common Stock share?

Eikon Therapeutics, Inc. Common Stock share touched a 52 week high of $ on January 1, 1970 and a 52 week low of $ on January 1, 1970. Eikon Therapeutics, Inc. Common Stock stock price today i.e. May 13, 2026 at 1:29 am IST is closed at $11.51,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Eikon Therapeutics, Inc. Common Stock's market capitalisation today?

Eikon Therapeutics, Inc. Common Stock market capitalisation is $0.00T as on May 13, 2026 at 1:29 am IST.

How to invest in Eikon Therapeutics, Inc. Common Stock Stock (EIKN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eikon Therapeutics, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eikon Therapeutics, Inc. Common Stock Shares that will get you 0.1303 shares as per Eikon Therapeutics, Inc. Common Stock share price of $11.51 per share as on May 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy Eikon Therapeutics, Inc. Common Stock Stock (EIKN) from India?

Indian investors can start investing in Eikon Therapeutics, Inc. Common Stock (EIKN) shares with as little as ₹95.618 or $1 (as of May 13, 2026 at 6:41 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Eikon Therapeutics, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:41 am IST). Based on Eikon Therapeutics, Inc. Common Stock share’s latest price of $11.51 as on May 13, 2026 at 1:29 am IST, you will get 0.8688 shares of Eikon Therapeutics, Inc. Common Stock. Learn more about fractional shares .